在产后期间接种人类乳头瘤病毒疫苗:系统性审查
Sara E Brenner1, Susan Modesitt, Robert A Bednarczyk
1Department of Gynecology and Obstetrics and the Division of Gynecologic Oncology, Emory University, and the Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia.
Obstetrics and gynecology
|August 29, 2024
概括
常规产后人类乳头瘤病毒 (HPV) 疫苗接种是可行的和可接受的,显著增加了接种率. 将HPV疫苗整合到产后护理中,为预防脆弱人群中与HPV相关的癌症提供了一个至关重要的机会.
科学领域:
- 生殖健康 生殖健康
- 疫苗学 疫苗学 疫苗学
- 公共卫生 公共卫生
背景情况:
- 产后是医疗保健参与的一个关键窗口.
- 人类乳头瘤病毒 (HPV) 感染是导致宫癌的主要原因.
- 在许多人群中,HPV疫苗接种率仍然很低.
研究的目的:
- 评估常规产后HPV疫苗接种的可接受性和可行性.
- 确定提高产后HPV疫苗接种率的策略.
主要方法:
- 在PubMed和ClinicalTrials.gov的系统文献搜索 (开始至2024年7月).
- 包括产后HPV疫苗接种的原始研究,评估接种率或可接受性.
- 对9项评估不同干预策略的研究进行分析.
主要成果:
- 产后HPV疫苗接种计划是可行的,并且得到了患者的良好接受.
- 这些计划表明,HPV疫苗接种率显著增加.
- 确定了关键主题和策略,以提高采用率.
结论:
- 将HPV疫苗接种纳入标准产后护理是一个可行的策略.
- 这种方法增加了弱势群体的获取机会,并降低了患者的成本.
- 常规产后HPV疫苗接种有可能预防与HPV相关的癌症.
更多相关视频
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
10.0K
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
3.5K
相关概念视频
01:51Vaccinations
44.2K
Overview
44.2K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347